Strain Data Sheet

RBRC05143

Strain Information

Image
BRC No.RBRC05143
TypeTargeted MutationCartagena
SpeciesMus musculus
Strain nameB6.129S2-Fad158<tm1Maim>/7Maim
Former Common nameB6-Fad158 KO#7
H-2 Haplotype
ES Cell lineD3 [129S2/SvPas]
Background strain
Appearance
Strain developmentDeveloped by Graduate School of Pharmaceutical Sciences, Nagoya City University and Genome Information Research Center, Osaka University in 2006. A neomycin selection cassette was inserted into the exon 4 of the Fad158 gene. C57BL/6J background.
Strain descriptionFad158 (Lrrc8c) knockout mice. Homozygous mutant mice do not show body weight gain and insulin resistance by a high-fat diet.
Colony maintenanceHeterozygote x Wild-type
References
The novel gene fad158, having a transmembrane domain and leucine-rich repeat, stimulates adipocyte differentiation.
Tominaga K, Kondo C, Kagata T, Hishida T, Nishizuka M, Imagawa M
J. Biol. Chem., 279, 34840-34848 (2004). 15184384

Factor for adipocyte differentiation 158 gene disruption prevents the body weight gain and insulin resistance induced by a high-fat diet.
Hayashi T, Nozaki Y, Nishizuka M, Ikawa M, Osada S, Imagawa M
Biol. Pharm. Bull., 34, 1257-1263 (2011). 21804215

Health Report

Examination Date / Room / Rack

Gene

Gene SymbolGene NameChr.Allele SymbolAllele NameCommon NamesPromoterDiseases Related to This Gene
Lrrc8cleucine rich repeat containing 8 family, member C5Lrrc8ctargeted mutation 1, Masayoshi Imagawa
neoneomycin resistance gene (E. coli)5mouse phosphoglycerate kinase promoter (PGK promoter)

Phenotype

Annotation by Mammalian phenotyhpe ontology
  • decreased body weight(MP:0001262)

  • decreased fluid intake(MP:0011942)

  • decreased liver weight(MP:0003402)

  • decreased susceptibility to diet-induced obesity(MP:0005659)

  • decreased white adipose tissue amount(MP:0001783)
    • more 1 phenotypes
  • increased insulin sensitivity(MP:0002891)
    • Detailed phenotype data

    Ordering Information

    Donor DNAmouse Pgk1 promoter, E. coli neomycin resistance gene, mouse Pgk1 polyA, mouse Fad158 genomic DNA
    Research applicationDiabetes and Obesity Research
    covid19_progression
    Specific Term and ConditionsIn publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Biol Pharm Bull. 2011 34(8):1257-63. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from Dr.Makoto Nishizuka (nishizuka@hirosaki-u.ac.jp) using the Approval Form. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE.
    DepositorMasayoshi Imagawa (Nagoya City University)
    Strain Statusan icon for Frozen embryosFrozen embryos
    an icon for Frozen spermFrozen sperm
    Strain AvailabilityRecovered litters from cryopreserved sperm (2 to 4 months)
    Cryopreserved sperm (within 1 month)
    Additional Info.Necessary documents for ordering:
    1. Approval form (Japanese / English)
    2. Order form (Japanese / English)
    3. Category I MTA: MTA for distribution with RIKEN BRC (Japanese / English)
    4. Acceptance of responsibility for living modified organism (Japanese / English)

    Genotyping protocol -PCR-

    BRC mice in Publications

    No Data